| Effectiveness of antipsychotic drugs in patients with chronic schizophrenia JA Lieberman, TS Stroup, JP McEvoy, MS Swartz, RA Rosenheck, ... New England journal of medicine 353 (12), 1209-1223, 2005 | 7590 | 2005 |
| Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia … JP McEvoy, JM Meyer, DC Goff, HA Nasrallah, SM Davis, L Sullivan, ... Schizophrenia research 80 (1), 19-32, 2005 | 1624 | 2005 |
| Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease LS Schneider, PN Tariot, KS Dagerman, SM Davis, JK Hsiao, MS Ismail, ... New England Journal of Medicine 355 (15), 1525-1538, 2006 | 1466 | 2006 |
| Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial RSE Keefe, RM Bilder, SM Davis, PD Harvey, BW Palmer, JM Gold, ... Archives of general psychiatry 64 (6), 633-647, 2007 | 1416 | 2007 |
| Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment JP McEvoy, JA Lieberman, TS Stroup, SM Davis, HY Meltzer, ... American Journal of Psychiatry 163 (4), 600-610, 2006 | 1235 | 2006 |
| Gender differences in treatment response to sertraline versus imipramine in chronic depression SG Kornstein, AF Schatzberg, ME Thase, KA Yonkers, JP McCullough, ... American Journal of Psychiatry 157 (9), 1445-1452, 2000 | 895 | 2000 |
| Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline HA Nasrallah, JM Meyer, DC Goff, JP McEvoy, SM Davis, TS Stroup, ... Schizophrenia research 86 (1-3), 15-22, 2006 | 749 | 2006 |
| A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls DC Goff, LM Sullivan, JP McEvoy, JM Meyer, HA Nasrallah, GL Daumit, ... Schizophrenia research 80 (1), 45-53, 2005 | 716 | 2005 |
| Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial AJ Rush, LB Marangell, HA Sackeim, MS George, SK Brannan, SM Davis, ... Biological psychiatry 58 (5), 347-354, 2005 | 679 | 2005 |
| Gender differences in chronic major and double depression SG Kornstein, AF Schatzberg, ME Thase, KA Yonkers, JP McCullough, ... Journal of Affective disorders 60 (1), 1-11, 2000 | 609 | 2000 |
| Baseline neurocognitive deficits in the CATIE schizophrenia trial RSE Keefe, RM Bilder, PD Harvey, SM Davis, BW Palmer, JM Gold, ... Neuropsychopharmacology 31 (9), 2033-2046, 2006 | 591 | 2006 |
| Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort RF Gottesman, MS Albert, A Alonso, LH Coker, J Coresh, SM Davis, ... JAMA neurology 74 (10), 1246-1254, 2017 | 582 | 2017 |
| Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic TS Stroup, JA Lieberman, JP McEvoy, MS Swartz, SM Davis, ... American Journal of Psychiatry 163 (4), 611-622, 2006 | 579 | 2006 |
| Search for physics beyond the standard model in dilepton mass spectra in proton-proton collisions at sqrt (s)= 8 TeV CMS collaboration arXiv preprint arXiv:1412.6302, 2014 | 473* | 2014 |
| The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine IW Miller, GI Keitner, AF Schatzberg, DN Klein, ME Thase, AJ Rush, ... The Journal of clinical psychiatry 59 (11), 21422, 1998 | 453 | 1998 |
| Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study AJ Rush, HA Sackeim, LB Marangell, MS George, SK Brannan, SM Davis, ... Biological psychiatry 58 (5), 355-363, 2005 | 450 | 2005 |
| A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression MS George, AJ Rush, LB Marangell, HA Sackeim, SK Brannan, SM Davis, ... Biological psychiatry 58 (5), 364-373, 2005 | 439 | 2005 |
| Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study MS Swartz, DO Perkins, TS Stroup, SM Davis, G Capuano, ... American Journal of Psychiatry 164 (3), 428-436, 2007 | 407 | 2007 |
| Clinical symptom responses to atypical antipsychotic medications in Alzheimer’s disease: phase 1 outcomes from the CATIE-AD effectiveness trial DL Sultzer, SM Davis, PN Tariot, KS Dagerman, BD Lebowitz, ... American Journal of Psychiatry 165 (7), 844-854, 2008 | 406 | 2008 |
| Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1 JM Meyer, VG Davis, DC Goff, JP McEvoy, HA Nasrallah, SM Davis, ... Schizophrenia research 101 (1-3), 273-286, 2008 | 395 | 2008 |
